Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease

Published:2004 Issue:4 Volume:38 Page:314-320
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr. Pulmonol.

Author:

Murphy Timothy D.,Anbar Ran D.,Lester Lucille A.,Nasr Samya Z.,Nickerson Bruce,VanDevanter Donald R.,Colin Andrew A.

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Reference18 articles.

1. Long-term tobramycin aerosol therapy in cystic fibrosis

2. Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis

3. Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis

4. Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis

5. Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized withPseudomonas aeruginosa

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brazilian guidelines for the pharmacological treatment of the pulmonary symptoms of cystic fibrosis. Official document of the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT, Brazilian Thoracic Association);Jornal Brasileiro de Pneumologia;2023-05-02

2. Incidence and associated risk factors for systemic drug levels with inhaled aminoglycoside therapy;Journal of Antimicrobial Chemotherapy;2022-12-13

3. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis;Cochrane Database of Systematic Reviews;2022-11-14

4. The Elusive Role of Airway Infection in Cystic Fibrosis Exacerbation;Journal of the Pediatric Infectious Diseases Society;2022-09-01

5. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis;Cochrane Database of Systematic Reviews;2022-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3